Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025npj Parkinson s DiseaseOpen Access

Elevated hexosylceramides in Parkinson’s disease cause gene upregulations in neurons mimicking responses to pathogens

View Full Paper
Ask AI
Bookmark
Share

Authors

LFLuisa FranckLHLisa HahnefeldLVLucie Valek

Discussion

Loading...

Member takes

Overview

Study identifies increased glucosylceramide in neurons from Parkinson's patients, suggesting innate immune response activation.

Key Points

  • Elevated glucosylceramide levels in Parkinson's disease patients trigger immune-like responses in neurons.
  • RNA sequencing revealed that glucosylceramide treatment upregulates glycolipid response genes in neurons.
  • Lipidomic analyses showed a significant accumulation of glucosylceramide, especially GlcCer24:1, in multiple PD models.
  • Findings indicate a potential role of glucosylceramide in the pathophysiology of Parkinson's disease, highlighting immune interactions.

Cite This Study

Franck et al. (2025) studied this question.

synapsesocial.com/papers/68c1d98f54b1d3bfb60fb70dhttps://doi.org/10.1038/s41531-025-01114-9
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Concept of Prodromal Parkinson’s Disease2015 · 293 citations
  2. 2Combinatorial targeting of glutamine metabolism and lysosomal-based lipid metabolism effectively suppresses glioblastoma2024 · 43 citations
  3. 3Autophagy activation, lipotoxicity and lysosomal membrane permeabilization synergize to promote pimozide- and loperamide-induced glioma cell death2021 · 112 citations
  4. 4Neuropathology of α‐synuclein propagation and braak hypothesis2015 · 135 citations
  5. 5The interplay between Glucocerebrosidase, α-synuclein and lipids in human models of Parkinson’s disease2020 · 58 citations